Metastasectomy for melanoma is associated with improved overall survival in responders to targeted molecular or immunotherapy-Reference-Cited by-同舟云学术

Metastasectomy for melanoma is associated with improved overall survival in responders to targeted molecular or immunotherapy

Published:2020-05-22 Issue:3 Volume:122 Page:555-561
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Medina Benjamin D.¹,Choi Beatrix Hyemin¹,Rodogiannis Kathy G.²,Moran Una²³,Shapiro Richard L.¹²,Pavlick Anna²⁴,Osman Iman²³,Berman Russell S.¹²^ORCID,Lee Ann Y.¹²^ORCID

Affiliation:

1. Division of Surgical Oncology, Department of Surgery New York University Langone Health New York New York

2. Interdisciplinary Melanoma Cooperative Group New York University Langone Health New York New York

3. Ronald O. Perelman Department of Dermatology New York University Langone Health New York New York

4. Division of Hematology and Oncology, Department of Medicine New York University Langone Health New York New York

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.25987

Reference27 articles.

1. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

2. Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

3. Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

4. Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

5. Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic resection for metastatic melanoma in the era of targeted therapy: A case report;International Journal of Surgery Case Reports;2024-08

2. Outcomes of Post-Immunotherapy Durable Responders of Advanced Hepatocellular Carcinoma– with Emphasis on Locoregional Therapy for Oligoprogression;Liver Cancer;2024-02-01

3. Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series;American Journal of Case Reports;2023-10-16

4. Current status and novel insights into the role of metastasectomy in the era of immunotherapy;Expert Review of Anticancer Therapy;2022-12-22

5. Clinical predictors of survival in real world practice in stage IV melanoma;Cancer Reports;2022-09-25